Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
67,028.02 +1,656.11 (+2.53%) CMC Crypto 200
1,366.79 -7.05 (-0.51%)
Rallybio Corporation (RLYB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.8600 |
| Open | 1.8600 |
| Bid | 1.7600 x 200 |
| Ask | 1.7900 x 200 |
| Day's range | 1.7625 - 1.8900 |
| 52-week range | 1.2250 - 9.1400 |
| Volume | |
| Avg. volume | 1,579,366 |
| Market cap | 73.365M |
| Beta (5Y monthly) | -1.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
RallyBio (RLYB) Partners With J&J & Gets $6.6M Funding, Stock Up
RallyBio (RLYB) gains 83% after announcing a collaboration deal with J&J to develop novel therapies to reduce the risk of FNAIT in pregnant women, along with funding of $6.6 million from the latter.
- Simply Wall St.
Is Rallybio (NASDAQ:RLYB) In A Good Position To Deliver On Growth Plans?
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
- Zacks
Wall Street Analysts Believe Rallybio Corporation (RLYB) Could Rally 202.36%: Here's is How to Trade
The mean of analysts' price targets for Rallybio Corporation (RLYB) points to a 202.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
© 2024 Yahoo. All rights reserved.